According to market analysts [BCC], the global nanomedicine sector, which was worth $53 billion in 2009, is projected to grow at a compound annual growth rate (CAGR) of 13.5%, surpassing $100 billion in 2014 (see Figure 1).
This graph shows the global nanomedicine market size, measured in terms of revenues, such as sales revenues, grants revenues, and milestones. From 2006 to date, a steady growth has occurred, which is expected to continue through 2014, at a CAGR of 13.5% [BCC Research, “Nanotechnology in Medical Applications: The Global Market,” 2010, inception].
The drug delivery market is the largest contributing application segment, whereas biomaterials is the fastest growing application area in this market. Nanomedicine accounts for 77 Marketed Products Worldwide, representing an Industry with an estimated market $130.9 Billion by 2016 [ETPN data, BCC].
One of the largest segments of this market is represented by drug delivery systems for the central nervous system, followed by anti-infectious, anti-inflammatory and anticancer products. Anticancer nanodrugs valued about $20 billion in 2009, it is expected to reach $33 billion in 2014, growing at a CAGR of 11%. It is expected to reach $12.7 billion by 2016, a CAGR of 18.2% between years 2011 and 2016. In Figure 2, a diagram on the nanomedical global sales in relation to therapeutic areas for the period 2009 – 2016 is presented.
Figure 2. This graph shows the nanomedical global sales in relation to major therapeutic areas for the period 2009 – 2016.